Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06791837 · ClinicalTrials.gov registry record

Brain Blood Flow and Lactate in Non-obese and Obese Subjects

A clinical trial of Obesity and Diabetes, sponsored by University of Missouri-Columbia.

Recruiting
Registry status
24
Enrollment target
1
Study location

NCT06791837: Recruiting study of Obesity and Diabetes, sponsored by University of Missouri-Columbia.

NCT06791837 is a study of Obesity and Diabetes that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 24 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06791837, a study of Obesity and Diabetes, is actively recruiting participants, sponsored by University of Missouri-Columbia.

RECRUITING
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

Cerebral blood flow (CBF) is essential for maintaining brain health and function, as it ensures delivery oxygen and nutrients necessary to support neuronal activity. Reduced CBF can impair the brain's ability to meet its metabolic demands, leading to deficits in cognitive ability. Impairments in CBF are associated with cognitive decline and neurodegenerative disease such as Alzheimer's and dementia. Many factors influence CBF, but recently lactate has emerged as a key player. Blood glucose has long been considered the primary fuel for the brain, but emerging evidence indicates that lactate may be the preferred fuel for neurons, and lactate may become even more important under stressful conditions. Individuals with obesity often have impaired lactate metabolism resulting in higher resting blood lactate concentrations and reduced ability to clear lactate after a physiological stress. At the same time, it is known that exercise is a powerful intervention for improving lactate metabolism. Thus, this project seeks to investigate the role of lactate in brain blood flow in individuals with and without obesity as well as establish if short term exercise training (individuals with obesity only) will alter circulating lactate concentrations at rest and in response to exercise.

Primary Outcome

Using transcranial doppler we will measure brain blood flow

Conditions Studied

Interventions

  • BEHAVIORAL EXERCISE

Study Locations (1)

Missouri

  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-05-01
Est. Completion 2027-03-01
University of Missouri-Columbia

291 total trials

What NCT06791837 shows while recruiting

NCT06791837 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which EXERCISE is the first listed.

NCT06791837 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT06791837 about?

NCT06791837 is a clinical study titled "Brain Blood Flow and Lactate in Non-obese and Obese Subjects". Cerebral blood flow (CBF) is essential for maintaining brain health and function, as it ensures delivery oxygen and nutrients necessary to support neuronal activity. Reduced CBF can impair the brain's ability to meet its metabolic demands, leading to deficits in cognitive ability. Impairments in CBF...

What is the current status of trial NCT06791837?

This trial is currently recruiting. The enrollment target is 24 participants. The study started on 2025-05-01. Estimated completion is 2027-03-01.

What conditions does trial NCT06791837 study?

This clinical trial studies the following conditions: Obesity, Diabetes.

What interventions are being tested in trial NCT06791837?

The interventions under investigation include: EXERCISE (BEHAVIORAL).

Who is sponsoring clinical trial NCT06791837?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06791837 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06791837's enrollment target sits among peer trials

24 909th of 1053 higher than 127 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06791837, the US trial registry maintained by the National Library of Medicine. NCT06791837 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.